Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Heelan

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Dermatology|May 3, 2012
Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experienceK Heelan, T Markham
British Dental Journal|January 16, 2016
A survey of oral medicine education, training and practice among dermatologists in the UK and IrelandK Heelan, D McKenna
Journal of the European Academy of Dermatology and Venereology : JEADV|July 30, 2013
Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based reviewK Heelan, S Knowles, S Walsh, et al.
Clinical and Experimental Dermatology|March 20, 2015
Pemphigus and associated comorbidities: a cross-sectional studyK Heelan, A L Mahar, S Walsh, et al.
The British Journal of Dermatology|December 19, 2014
Intractable erosive lichen planus treated successfully with rituximabK Heelan, M A McAleer, L Roche, et al.
Clinical and Experimental Dermatology|May 15, 2018
Localized genital bullous pemphigoidS J Mounsey, K Heelan, S Hughes, et al.
Clinical and Experimental Dermatology|October 9, 2018
A survey of the treatment and management of patients with severe chronic spontaneous urticariaB Ho, K Heelan, L Solman, et al.
Skin Health and Disease|June 6, 2022
Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapyL Ferguson, B Ho, J Weir, et al.
Journal of Cutaneous Medicine and Surgery|April 19, 2015
Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous DermatosesK Heelan, S L Hitzig, S Knowles, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Dermatology|May 3, 2012
Fumaric acid esters as a suitable first-line treatment for severe psoriasis: an Irish experienceK Heelan, T Markham
British Dental Journal|January 16, 2016
A survey of oral medicine education, training and practice among dermatologists in the UK and IrelandK Heelan, D McKenna
Journal of the European Academy of Dermatology and Venereology : JEADV|July 30, 2013
Effect of concomitant statin use on rituximab treatment for pemphigus and pemphigoid disorders: a case-based reviewK Heelan, S Knowles, S Walsh, et al.
Clinical and Experimental Dermatology|March 20, 2015
Pemphigus and associated comorbidities: a cross-sectional studyK Heelan, A L Mahar, S Walsh, et al.
The British Journal of Dermatology|December 19, 2014
Intractable erosive lichen planus treated successfully with rituximabK Heelan, M A McAleer, L Roche, et al.
Clinical and Experimental Dermatology|May 15, 2018
Localized genital bullous pemphigoidS J Mounsey, K Heelan, S Hughes, et al.
Clinical and Experimental Dermatology|October 9, 2018
A survey of the treatment and management of patients with severe chronic spontaneous urticariaB Ho, K Heelan, L Solman, et al.
Skin Health and Disease|June 6, 2022
Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapyL Ferguson, B Ho, J Weir, et al.
Journal of Cutaneous Medicine and Surgery|April 19, 2015
Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous DermatosesK Heelan, S L Hitzig, S Knowles, et al.
Clinical and Experimental Dermatology|October 3, 2020
Cutaneous toxicities in patients with melanoma receiving checkpoint inhibitor therapy: a retrospective review. The experience of a single large specialist institutionC L Edwards, F Comito, S Agraso Busto, et al.
Pageof 1